• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection.上呼吸道病毒载量、合并症、疾病严重程度与 SARS-CoV-2 感染患者结局的关系。
J Infect Dis. 2021 Apr 8;223(7):1132-1138. doi: 10.1093/infdis/jiaa804.
2
Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.从轻症感染患者的鼻咽样本中定量检测 SARS-CoV-2 RNA。
J Med Virol. 2021 Apr;93(4):2439-2445. doi: 10.1002/jmv.26761. Epub 2021 Jan 5.
3
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome.鼻咽拭子中的 SARS-CoV-2 病毒载量不是不良结局的独立预测因子。
Sci Rep. 2021 Jun 21;11(1):12931. doi: 10.1038/s41598-021-92400-y.
4
SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.SARS-CoV-2 感染和病毒载量与上呼吸道微生物组有关。
J Allergy Clin Immunol. 2021 Apr;147(4):1226-1233.e2. doi: 10.1016/j.jaci.2021.02.001. Epub 2021 Feb 9.
5
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.新型冠状病毒肺炎患者的严重急性呼吸综合征冠状病毒2病毒载量,并与其他呼吸道病毒进行比较。
Microbes Infect. 2020 Nov-Dec;22(10):617-621. doi: 10.1016/j.micinf.2020.08.004. Epub 2020 Sep 7.
6
Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.无症状和有症状儿童 SARS-CoV-2 感染的儿科医院检测计划中,上呼吸道病毒载量分布的比较。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02593-20.
7
Investigation of Viral Load Cycle Threshold Values in Patients with SARS-CoV-2 Associated Pneumonia with Real-Time PCR Method.应用实时 PCR 方法研究与 SARS-CoV-2 相关肺炎患者的病毒载量循环阈值。
J Infect Dev Ctries. 2021 Oct 31;15(10):1408-1414. doi: 10.3855/jidc.14281.
8
SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic.严重急性呼吸综合征冠状病毒 2 型感染:初始病毒载量(iVL)可预测疾病严重程度/结局,住院患者 iVL 的下降趋势与大流行的减缓相对应。
PLoS One. 2021 Sep 16;16(9):e0255981. doi: 10.1371/journal.pone.0255981. eCollection 2021.
9
Lack of correlation between the SARS-CoV-2 cycle threshold (C ) value and clinical outcomes in patients with COVID-19.SARS-CoV-2 循环阈值(Ct)值与 COVID-19 患者临床结局之间缺乏相关性。
J Med Virol. 2021 Oct;93(10):6059-6062. doi: 10.1002/jmv.27171. Epub 2021 Jul 6.
10
Symptomatic Infants Have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease Than Older Children.有症状的婴儿鼻咽部严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒载量较高,但病情比大龄儿童轻。
Clin Infect Dis. 2020 Nov 19;71(16):2305-2306. doi: 10.1093/cid/ciaa608.

引用本文的文献

1
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.美普珠单抗(一种CD147抗体)用于治疗重症新型冠状病毒肺炎:一项双盲、随机、安慰剂对照的3期临床试验。
Signal Transduct Target Ther. 2025 Apr 14;10(1):119. doi: 10.1038/s41392-025-02208-9.
2
Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations.通过整合 RNA-Seq 和分子动力学模拟,探索 Epstein Barr 病毒感染与长新冠之间的常见致病关联。
Front Immunol. 2024 Sep 26;15:1435170. doi: 10.3389/fimmu.2024.1435170. eCollection 2024.
3
Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial.阿斯托地瑞钠鼻喷雾剂与安慰剂用于非住院COVID-19患者的对照研究:一项随机、双盲、安慰剂对照试验
Pharmaceutics. 2024 Sep 6;16(9):1173. doi: 10.3390/pharmaceutics16091173.
4
A retrospective analysis of the influencing factors of nucleic acid CT value fluctuation in COVID-19 patients infected with Omicron variant virus in Changchun city.长春市感染奥密克戎变异株的新冠病毒患者核酸 CT 值波动影响因素的回顾性分析。
Front Public Health. 2024 Jun 14;12:1377135. doi: 10.3389/fpubh.2024.1377135. eCollection 2024.
5
Associations between epidemiological and laboratory parameters and disease severity in hospitalized patients with COVID-19 during first and second epidemic waves in middle south Mato Grosso.中南部马托格罗索州 COVID-19 大流行第一波和第二波期间住院患者的流行病学和实验室参数与疾病严重程度的相关性。
Braz J Microbiol. 2024 Sep;55(3):2613-2629. doi: 10.1007/s42770-024-01379-x. Epub 2024 Jun 5.
6
Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy.意大利一家三级儿科医院收治患儿中多种呼吸道病毒感染的存在及意义。
Viruses. 2024 May 9;16(5):750. doi: 10.3390/v16050750.
7
Association between SARS-CoV-2 gene specific Ct values and COVID-19 associated in-hospital mortality.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因特异性Ct值与新型冠状病毒肺炎(COVID-19)相关院内死亡率之间的关联
Front Epidemiol. 2024 Apr 26;4:1375975. doi: 10.3389/fepid.2024.1375975. eCollection 2024.
8
Outcomes of home-isolated coronavirus disease 2019 patients in Bahrain.巴林2019冠状病毒病居家隔离患者的结局
J Family Community Med. 2023 Jul-Sep;30(3):211-218. doi: 10.4103/jfcm.jfcm_10_23. Epub 2023 Jul 24.
9
Immune Status and SARS-CoV-2 Viral Dynamics.免疫状态与 SARS-CoV-2 病毒动力学。
J Infect Dis. 2023 Aug 31;228(Suppl 2):S111-S116. doi: 10.1093/infdis/jiad200.
10
Differential expression of antiviral and immune-related genes in individuals with COVID-19 asymptomatic or with mild symptoms.COVID-19 无症状感染者和轻症患者体内抗病毒和免疫相关基因的差异表达。
Front Cell Infect Microbiol. 2023 Jun 14;13:1173213. doi: 10.3389/fcimb.2023.1173213. eCollection 2023.

上呼吸道病毒载量、合并症、疾病严重程度与 SARS-CoV-2 感染患者结局的关系。

Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection.

机构信息

Directorate of Research, Studies, and Documentation, National Public Health Organization, Athens, Greece.

Epidemiological Surveillance of HIV/AIDS Division, National Public Health Organization, Athens, Greece.

出版信息

J Infect Dis. 2021 Apr 8;223(7):1132-1138. doi: 10.1093/infdis/jiaa804.

DOI:10.1093/infdis/jiaa804
PMID:33388780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7798974/
Abstract

BACKGROUND

There is limited information on the association between upper respiratory tract (URT) viral loads, host factors, and disease severity in SARS-CoV-2-infected patients.

METHODS

We studied 1122 patients (mean age, 46 years) diagnosed by polymerase chain reaction (PCR). URT viral load, measured by PCR cycle threshold, was categorized as high, moderate, or low.

RESULTS

There were 336 (29.9%) patients with comorbidities; 309 patients (27.5%) had high, 316 (28.2%) moderate, and 497 (44.3%) low viral load. In univariate analyses, compared to patients with moderate or low viral load, patients with high viral load were older, more often had comorbidities, developed Symptomatic disease (COVID-19), were intubated, and died. Patients with high viral load had longer stay in intensive care unit and longer intubation compared to patients with low viral load (P values < .05 for all comparisons). Patients with chronic cardiovascular disease, hypertension, chronic pulmonary disease, immunosuppression, obesity, and chronic neurological disease more often had high viral load (P value < .05 for all comparisons). In multivariate analysis high viral load was associated with COVID-19. Level of viral load was not associated with any other outcome.

CONCLUSIONS

URT viral load could be used to identify patients at higher risk for morbidity or severe outcome.

摘要

背景

关于 SARS-CoV-2 感染患者上呼吸道 (URT) 病毒载量、宿主因素和疾病严重程度之间的关联,信息有限。

方法

我们研究了 1122 名经聚合酶链反应 (PCR) 诊断的患者(平均年龄 46 岁)。通过 PCR 循环阈值将 URT 病毒载量分为高、中、低。

结果

336 名(29.9%)患者合并症;309 名患者(27.5%)病毒载量高,316 名(28.2%)病毒载量中等,497 名(44.3%)病毒载量低。在单因素分析中,与中或低病毒载量患者相比,高病毒载量患者年龄较大,合并症较多,出现症状性疾病(COVID-19),需要插管,并且死亡。与低病毒载量患者相比,高病毒载量患者入住重症监护病房时间更长,插管时间更长(所有比较的 P 值均<.05)。患有慢性心血管疾病、高血压、慢性肺部疾病、免疫抑制、肥胖和慢性神经疾病的患者更常出现高病毒载量(所有比较的 P 值均<.05)。多变量分析显示,高病毒载量与 COVID-19 相关。病毒载量水平与任何其他结局均无关。

结论

URT 病毒载量可用于识别发病率或严重后果风险较高的患者。